Sex-Related Differences in Dispensation of Rheumatic Medications in Older Patients With Inflammatory Arthritis: A Population-Based Study

REFERENCES

1. 1.↵
   1. Smolen JS,
   2. Aletaha D,
   3. Barton A, et al.

   Rheumatoid arthritis. Nat Rev Dis Primer 2018;4:18001.

   OpenUrl
2. 2.↵
   1. McLaughlin M,
   2. Ostör A.

   Early treatment of psoriatic arthritis improves prognosis. Practitioner 2014;258:21-4.

   OpenUrlPubMed
3. 3.↵
   1. Favalli EG,
   2. Biggioggero M,
   3. Crotti C,
   4. Becciolini A,
   5. Raimondo MG,
   6. Meroni PL.

   Sex and management of rheumatoid arthritis. Clin Rev Allergy Immunol 2019;56:333-45.

   OpenUrl
4. 4.↵
   1. Tarannum S,
   2. Leung YY,
   3. Johnson SR, et al.

   Sex- and gender-related differences in psoriatic arthritis. Nat Rev Rheumatol 2022; 18:513-26.

   OpenUrl
5. 5.↵
   1. Arkema EV,
   2. Neovius M,
   3. Joelsson JK,
   4. Simard JF,
   5. van Vollenhoven RF.

   Is there a sex bias in prescribing anti-tumour necrosis factor medications to patients with rheumatoid arthritis? A nation-wide cross-sectional study. Ann Rheum Dis 2012;71:1203-6.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Gossen N,
   2. Jacob L,
   3. Kostev K.

   Second-line therapy with biological drugs in rheumatoid arthritis patients in German rheumatologist practices: a retrospective database analysis. Rheumatol Int 2016;36:1113-8.

   OpenUrl
7. 7.↵
   1. Lacaille D,
   2. Anis AH,
   3. Guh DP,
   4. Esdaile JM.

   Gaps in care for rheumatoid arthritis: a population study. Arthritis Care Res 2005;53:241-8.

   OpenUrlCrossRef
8. 8.↵
   1. Jin Y,
   2. Desai RJ,
   3. Liu J,
   4. Choi NK,
   5. Kim SC.

   Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis. Arthritis Res Ther 2017;19:159.

   OpenUrl
9. 9.↵
   1. Steffen A,
   2. Holstiege J,
   3. Klimke K,
   4. Akmatov MK,
   5. Bätzing J.

   Patterns of the initiation of disease-modifying antirheumatic drugs in incident rheumatoid arthritis: a German perspective based on nationwide ambulatory drug prescription data. Rheumatol Int 2018;38:2111-20.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Slim Z,
    2. Moura CS,
    3. Bernatsky S,
    4. Rahme E.

    Care quality for rheumatoid arthritis patients in Quebec. Int J Rheum Dis 2019;22:1233-8.

    OpenUrl
11. 11.↵
    1. Rochon P,
    2. Pratt M,
    3. Rawdat R.

    The impact of sex and gender on prescribing cascades in older adults. Healthc Q 2023;25:6-9.

    OpenUrl
12. 12.↵
    1. Widdifield J,
    2. Bernatsky S,
    3. Paterson JM, et al.

    Accuracy of Canadian health administrative databases in identifying patients with rheumatoid arthritis: a validation study using the medical records of rheumatologists. Arthritis Care Res 2013;65:1582-91.

    OpenUrlPubMed
13. 13.↵
    1. Eder L,
    2. Widdifield J,
    3. Rosen CF, et al.

    Identifying and characterizing psoriasis and psoriatic arthritis patients in Ontario administrative data: a population-based study from 1991 to 2015. J Rheumatol 2020;47:1644-51.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Tarannum S,
    2. Widdifield J,
    3. Wu CF,
    4. Johnson SR,
    5. Rochon P,
    6. Eder L.

    Understanding sex-related differences in healthcare utilisation among patients with inflammatory arthritis: a population-based study. Ann Rheum Dis 2023;82:283-91.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Starfield B,
    2. Weiner J,
    3. Mumford L,
    4. Steinwachs D.

    Ambulatory care groups: a categorization of diagnoses for research and management. Health Serv Res 1991;26:53-74.

    OpenUrlPubMed
16. 16.↵
    1. Passia E,
    2. Vis M,
    3. Coates LC, et al.

    Sex-specific differences and how to handle them in early psoriatic arthritis. Arthritis Res Ther 2022;24:22.

    OpenUrlPubMed
17. 17.↵
    1. Albrecht K,
    2. Regierer AC,
    3. Strangfeld A,
    4. Marschall U,
    5. Callhoff J.

    High burden of polypharmacy and comorbidity in persons with psoriatic arthritis: an analysis of claims data, stratified by age and sex. RMD Open 2023;9:e002960.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Mease PJ.

    Fibromyalgia, a missed comorbidity in spondyloarthritis: prevalence and impact on assessment and treatment. Curr Opin Rheumatol 2017;29:304-10.

    OpenUrlPubMed
19. 19.↵
    1. McHugh RK,
    2. DeVito EE,
    3. Dodd D, et al.

    Gender differences in a clinical trial for prescription opioid dependence. J Subst Abuse Treat 2013;45:38-43.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Alswat KA.

    Gender disparities in osteoporosis. J Clin Med Res 2017;9:382-7.

    OpenUrl